Clinical Trials Logo

Clinical Trial Summary

This is a validation study recruiting subjects with and without obstructive sleep apnea. All subjects will undergo a nocturnal standard polysomnography and UMindSleep assessment. Sleep parameters, such as sleep stages and apnea UMindSleep software. Correlation in each parameter between PSG and events in polysomnography (PSG) will be scored according to the AASM criteria while the sleep parameters will be automatically scored by the UMindSleep will be analyzed to determine the magnitude of agreement between UMindSleep and PSG.


Clinical Trial Description

Obstructive sleep apnea (OSA) is a common sleep disorder in the general population with a prevalence ranging from 4-30%. OSA has been shown to be a significant risk factor of many cardiovascular diseases and mental disorders. However, OSA is a neglected problem in the general population. In addition, there is a significant unmet need for the treatment of OSA. One of the major reason for the under-diagnosis and under-treatment of OSA in the general population is a lack of reliable screening tool in detecting OSA. In this regard, several devices, such as ApneaLink, have been developed for the screening of OSA. However, as this kind of device only employs time in bed rather than actual sleep time to calculate the apnea index or desaturation index, they tend to underestimate the severity of sleep apnea. In this regard, it is timely need to develop and validate new device that can integrate the actual sleep time and apnea or desaturation events for the precise calculation of sleep apnea index or desaturation index.

The UMindSleep is a handy and wearable device to acquire EEG, heart rate, saturation, snoring and temperature. The signal will be uploaded to a smartphone through Bluetooth. By integrating these signals, the system can automatically analyze several key parameters by the algorithms, such as sleep stages and desaturation events. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04208672
Study type Interventional
Source Chinese University of Hong Kong
Contact Mandy Yu, MPH
Phone 852-39197593
Email mandyyu@cuhk.edu.hk
Status Not yet recruiting
Phase N/A
Start date January 16, 2020
Completion date September 15, 2020

See also
  Status Clinical Trial Phase
Terminated NCT02377609 - To Validate an Analytical Method to Measure Concentration of Tacrolimus in Blood Taken From Finger Pricks N/A
Completed NCT05236101 - Validation of Child Drawing Hospital Scale (CD: H) and the Place of the Drawing in the Evaluation of Dental Anxiety N/A
Completed NCT02845128 - Prospective Validation of the ROX Index
Completed NCT04778007 - The Validation of the Turkish Version of the LUMP Questionnaire
Recruiting NCT05871411 - Validation of Visual Analog Scales to Measure SatisfactiOn and WELL-being at Work (SoWell-VAS)
Completed NCT03162835 - Development and Clinimetric Properties of the Dutch Pediatric Neurophysiology of Pain Questionnaire in Healthy Children
Not yet recruiting NCT06392698 - The Danish Version of the Surgical Fear Questionnaire
Recruiting NCT05970835 - Validation of a Mobile App as an Adjuvant Treatment N/A
Completed NCT04465903 - Validity and Reliability of the Turkish Version of the Sydney Swallow Questionnaire
Completed NCT04477174 - Validity and Reliability of the Turkish Translation of the Yale Pharyngeal Residue Severity Rating Scale
Completed NCT02625285 - Validation of New G6PD Point of Care Tests Against Gold Standard Quantitative N/A
Completed NCT00340756 - Evaluating Serum Sex Steroid Hormones N/A
Completed NCT05678920 - Validation of the Turkish Version of the Modified Early Obstetric Warning Systems (MEOWS) Charts